Verition Fund Management LLC Cytek Biosciences, Inc. Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 13,642 shares of CTKB stock, worth $65,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,642
Previous 37,942
64.05%
Holding current value
$65,618
Previous $210,000
58.1%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CTKB
# of Institutions
150Shares Held
74MCall Options Held
1KPut Options Held
0-
Black Rock Inc. New York, NY17.1MShares$82.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$56.4 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD8.25MShares$39.7 Million1.27% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$32 Million1.65% of portfolio
-
State Street Corp Boston, MA4.51MShares$21.7 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $648M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...